# Justin Wright-Eakes

> Justin Wright-Eakes is a seed investor at Oval Park Capital backing Software and Infrastructure. See 13 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Oval Park Capital](https://shizune.co/investors/profile/oval-park-capital)
- Location: Raleigh, United States
- Total investments: 13
- Last investment: Dec 2025
- Lead investor: 54%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/opcjwe/

Justin Wright-Eakes is a seed investor at Oval Park Capital in Raleigh focused on Software and Infrastructure. Justin W is the Managing Partner at Oval Park Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 3 | 23% |
| Infrastructure | 2 | 15% |
| Artificial Intelligence | 2 | 15% |
| Environmental Engineering | 2 | 15% |
| SaaS | 1 | 8% |

23 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 5 | 38% |
| Series A | 4 | 31% |
| Series B | 2 | 15% |
| Series C | 1 | 8% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lemurian Labs | Lemurian Labs has created a universal platform that works across any hardware and spans compiler technology and runtime orchestration. This streamlined, hardware-agnostic approach simplifies AI development, enabling organizations to write code once and deploy it seamlessly across edge, cloud and on-premise environments. By cutting through thecomplexity of fragmented software ecosystems, Lemurian Labs empowers businesses to build and scale AI efficiently, affordably and responsibly—unlocking the full potential of AI innovation without proprietary constraints. | $28M | Series A | Dec 03, 2025 |  |
| Extellis | Extellis is a satellite imaging company focused on delivering reliable Earth observation data at an industrial scale with affordable and high-volume capacity. which allows satellites to capture real-time images in all weather conditions, 24/7. This technology enables Extellis to offer high-capacity satellite imaging that can monitor changesanywhere on Earth as they happen, overcoming limitations of current satellites that cannot take enough images daily for continuous monitoring. | $6.8M | Seed | Nov 10, 2025 |  |
| Natrx | Natrx uses advanced technology to deliver high-performance, nature-based solutions to coastal resilience and protection challenges at industrial scale. Traditional methods for climate resilience and infrastructure protection are expensive, ecologically damaging, and unreliable. Natrx takes a technology-first approach in addressing thesechallenges­—creating practical, sustainable, and large-scale solutions that deliver high-performance and natural beauty. | $3.5M | Seed | Oct 11, 2023 |  |
| Lemurian Labs | Lemurian Labs has created a universal platform that works across any hardware and spans compiler technology and runtime orchestration. This streamlined, hardware-agnostic approach simplifies AI development, enabling organizations to write code once and deploy it seamlessly across edge, cloud and on-premise environments. By cutting through thecomplexity of fragmented software ecosystems, Lemurian Labs empowers businesses to build and scale AI efficiently, affordably and responsibly—unlocking the full potential of AI innovation without proprietary constraints. | $9M | Seed | Sep 08, 2023 |  |
| Emrgy | Founded in 2014, Emrgy Inc. is a transformational technology company that is redefining hydropower to remain the world’s most reliable, continuous, and cost-effective renewable energy resource in an energy economy shifting to distributed, intermittent renewables. | $18.4M | Series A | Apr 11, 2023 |  |
| Archaius | Archaius develops a patented field and phase technology to deliver Assured Positioning, Navigation, and Timing. Founded in 2019, Archaius is based in Durham, North Carolina. | $1.1M | Seed | Jul 11, 2022 |  |
| TARGAN | Applied LifeSciences & Systems is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effectivevaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick. | $35M | Series C | May 25, 2022 |  |
| Medicom Technologies | Medicom provides a platform for secure exchange and use of medical imaging data in clinical and research settings. The company offers solutions that automate the retrieval, sharing, and integration of imaging studies into electronic health records, helping care teams access complete patient information without manual processes.Its platformincludes tools for interoperable data exchange, workflow automation, and de-identification of imaging data for research and analytics. These capabilities support both clinical operations and the creation of structured datasets for research, including applications in artificial intelligence and medical studies.Medicom also develops technologies that enable secure, peer-to-peer data sharing and centralized visibility across distributed healthcare systems, improving coordination between providers and supporting data-driven healthcare workflows. | $21.8M | Series B | Nov 18, 2021 |  |
| TARGAN | Applied LifeSciences & Systems is a bio-systems company focused on improving animal health and productivity in the poultry, livestock, and aquaculture industries. ALS-S is developing a solution that revolutionizes current vaccination methods. Our technology will detect, target, and deliver vaccines to each and every chick, ensuring effectivevaccination. This one-of-a-kind accuracy and consistency in the vaccination process boosts the natural immune response to diseases, improves overall flock health, and provides for a cleaner, healthier chick. | $7M | Series B | May 12, 2021 |  |
| NALA Membranes | NALA provides uniquely chlorine stable reverse osmosis membranes that improve efficiency and reduce waste and energy in today’s advanced water treatment operations. NALA’s unique and patented materials result in durable membranes that foul and fail less, even in the most challenging industrial wastewater applications. By reducing operating cost andgreenhouse gas emissions, NALA Membranes are good for business and the environment. | $700K | Seed | Jan 15, 2021 |  |

10 of 13 investments shown.

## Co-investors
- [Mountain Group Capital](https://shizune.co/investors/profile/mountain-group-capital) — VC Fund, 3 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 2 deals together
- [Dynamic Leap](https://shizune.co/investors/profile/dynamic-leap) — VC Fund, 2 deals together
- [Good Growth Capital](https://shizune.co/investors/profile/good-growth-capital) — VC Fund, 2 deals together
- [Merck Animal Health Ventures](https://shizune.co/investors/profile/merck-animal-health-ventures) — VC Fund, 2 deals together
- [Untapped Ventures](https://shizune.co/investors/profile/untapped-ventures) — VC Fund, 2 deals together

## About Oval Park Capital

VC Fund · Raleigh, United States

Oval Park Capital they give services for industries such as healthcare, financial, cybersecurity, agricultural, sustainable food, animal health, clean energy, water, construction, and industrial technologies.

1 contacts available at Oval Park Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Justin Wright-Eakes | Managing Partner | https://shizune.co/investors/profile/justin-wright-eakes |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Justin Wright-Eakes invest in?

Justin Wright-Eakes invests primarily in Software, Infrastructure and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Justin Wright-Eakes last invest?

The most recent investment recorded for Justin Wright-Eakes closed in Dec 2025. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co